Changes in Magnetic Resonance Imaging Disease Measures Over 3 Years in Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) Study

BMC Neurology - United Kingdom
doi 10.1186/1471-2377-11-125

Related search